Vanda Pharmaceuticals Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Washington, DC
SEC filing record 1 source field available
Fiscal year end
31 December
Vanda Pharmaceuticals Inc. has filed 1,327 SEC EDGAR filings since 29 Dec 2005

SEC filing history

Showing 1-25 of 954 matching filings.

Per page
25
Current page
1
4

4

Filing date
08 Jun 2026
Reporting date
04 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Jun 2026
Reporting date
04 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Jun 2026
Reporting date
04 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Jun 2026
Reporting date
04 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Jun 2026
Reporting date
04 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Jun 2026
Reporting date
04 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Jun 2026
Reporting date
04 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
08 Jun 2026
Reporting date
04 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-296555

S-8

Filing date
05 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 May 2026
Reporting date
18 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-82196

SCHEDULE 13G filing

Filing date
12 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-293404

EFFECT filing

Filing date
05 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-82196

SCHEDULE 13G/A filing

Filing date
29 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
24 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
24 Apr 2026
Reporting date
22 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
24 Apr 2026
Reporting date
22 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-34186

ARS

Filing date
23 Apr 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-34186

DEFA14A

Filing date
23 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-34186

DEF 14A

Filing date
23 Apr 2026
Reporting date
04 Jun 2026
Next action
Verify source filing
3

3

Filing date
13 Apr 2026
Reporting date
01 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
13 Apr 2026
Reporting date
01 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .